The Irish Times has today reported that Pfizer will create up to 350 new jobs with its latest multimillion euro expansion of its Grange Castle Campus in Dublin.
According to an Environmental Impact Statement (EIS) filed with the planning permission, the first phase of the expansion will deliver 200 new jobs when fully operational, on top of the 1,100 currently working there.
A further 100 people are expected to be employed following the completion of the second phase.
The US company is looking to build a five-storey biopharma manufacturing unit in two phases, adding more than 34,500sq m to its current footprint on what is already one of the largest biotechnology plants in the world.
The project amounts to an investment of between €300 million and €400 million on the former Wyeth site which produces some of Pfizer’s biggest drugs, including the arthritis blockbuster Enbrel and the vaccine Prevenar, which is used in children to prevent pneumococcal infections.
According to the documents, the expansion will take between 24 and 27 months to complete once excavation begins. That is expected to be some time next year. Securing regulatory approval for biopharma production means the new facilities are not expected to be operational until 2020.
Pfizer, which has had a presence in Ireland since 1969, and currently employs more than 3,300 people across seven sites in Cork, Dublin, Kildare and Sligo, has said it intends to seek a 10-year permission for the development.
Source: www.businessworld.ie